Yuliana Yosaatmadja
Yuliana Yosaatmadja
Verified email at
Cited by
Cited by
Binding mode of the breakthrough inhibitor AZD9291 to epidermal growth factor receptor revealed
Y Yosaatmadja, S Silva, JM Dickson, AV Patterson, JB Smaill, ...
Journal of structural biology 192 (3), 539-544, 2015
Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase
JA Newman, A Douangamath, S Yadzani, Y Yosaatmadja, A Aimon, ...
Nature Communications 12 (1), 4848, 2021
TAS‐120 cancer target binding: defining reactivity and revealing the first fibroblast growth factor receptor 1 (FGFR1) irreversible structure
M Kalyukina, Y Yosaatmadja, MJ Middleditch, AV Patterson, JB Smaill, ...
ChemMedChem 14 (4), 494-500, 2019
Crystal structures of three classes of non-steroidal anti-inflammatory drugs in complex with aldo-keto reductase 1C3
JU Flanagan, Y Yosaatmadja, RM Teague, MZL Chai, AP Turnbull, ...
Public Library of Science 7 (8), e43965, 2012
The interaction of human neuroglobin with hydrogen sulphide
T Brittain, Y Yosaatmadja, K Henty
IUBMB life 60 (2), 135-138, 2008
Radiation damage and racemic protein crystallography reveal the unique structure of the GASA/snakin protein superfamily
H Yeung, CJ Squire, Y Yosaatmadja, S Panjikar, G López, A Molina, ...
Angewandte Chemie 128 (28), 8062-8065, 2016
Structures of human peroxiredoxin 3 suggest self-chaperoning assembly that maintains catalytic state
NA Yewdall, H Venugopal, A Desfosses, V Abrishami, Y Yosaatmadja, ...
Structure 24 (7), 1120-1129, 2016
Characterization of the SARS-CoV-2 ExoN (nsp14ExoN–nsp10) complex: implications for its role in viral genome stability and inhibitor identification
HT Baddock, S Brolih, Y Yosaatmadja, M Ratnaweera, M Bielinski, ...
Nucleic acids research 50 (3), 1484-1500, 2022
Mechanistic and evolutionary insights from the reciprocal promiscuity of two pyridoxal phosphate-dependent enzymes
VWC Soo, Y Yosaatmadja, CJ Squire, WM Patrick
Journal of Biological Chemistry 291 (38), 19873-19887, 2016
The 1.65 Å resolution structure of the complex of AZD4547 with the kinase domain of FGFR1 displays exquisite molecular recognition
Y Yosaatmadja, AV Patterson, JB Smaill, CJ Squire
Acta Crystallographica Section D: Biological Crystallography 71 (3), 525-533, 2015
Harnessing ester bond chemistry for protein ligation
PG Young, Y Yosaatmadja, PWR Harris, IKH Leung, EN Baker, CJ Squire
Chemical communications 53 (9), 1502-1505, 2017
2-Oxo-3, 4-dihydropyrimido [4, 5-d] pyrimidinyl derivatives as new irreversible pan fibroblast growth factor receptor (FGFR) inhibitors
X Li, CP Guise, R Taghipouran, Y Yosaatmadja, A Ashoorzadeh, WK Paik, ...
European Journal of Medicinal Chemistry 135, 531-543, 2017
The SNM1A DNA repair nuclease
HT Baddock, Y Yosaatmadja, JA Newman, CJ Schofield, O Gileadi, ...
DNA repair 95, 102941, 2020
Structural and mechanistic insights into the Artemis endonuclease and strategies for its inhibition
Y Yosaatmadja, HT Baddock, JA Newman, M Bielinski, AE Gavard, ...
Nucleic acids research 49 (16), 9310-9326, 2021
Rotational freedom, steric hindrance, and protein dynamics explain BLU554 selectivity for the hinge cysteine of FGFR4
X Lin, Y Yosaatmadja, M Kalyukina, MJ Middleditch, Z Zhang, X Lu, ...
ACS Medicinal Chemistry Letters 10 (8), 1180-1186, 2019
Structure of AKR1C3 with 3-phenoxybenzoic acid bound
VJ Jackson, Y Yosaatmadja, JU Flanagan, CJ Squire
Acta Crystallographica Section F: Structural Biology and Crystallization …, 2012
1.85 angstrom structure of EGFR kinase domain with gefitinib
Y Yosaatmadja, C Squire, C McKeage, M Flanagan
To Be Publ, 2014
A phosphate binding pocket is a key determinant of exo-versus endo-nucleolytic activity in the SNM1 nuclease family
HT Baddock, JA Newman, Y Yosaatmadja, M Bielinski, CJ Schofield, ...
Nucleic Acids Research 49 (16), 9294-9309, 2021
Characterisation of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification. bioRxiv; 2020 August 13 …
HT Baddock, S Brolih, Y Yosaatmadja, M Ratnaweera, M Bielinski, ...
Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal details of exoribonuclease activation and mRNA capping and provide starting points for antiviral drug …
N Imprachim, Y Yosaatmadja, JA Newman
Nucleic Acids Research 51 (1), 475-487, 2023
The system can't perform the operation now. Try again later.
Articles 1–20